Nina Paleologos to Erlotinib Hydrochloride
This is a "connection" page, showing publications Nina Paleologos has written about Erlotinib Hydrochloride.
Connection Strength
0.136
-
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol. 2016 Jan; 126(1):185-192.
Score: 0.136
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.